21 West Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$393K Sell
340
-11
-3% -$13K 0.34% 50
2026
Q2
$421K Hold
351
– – 0.36% 51
2026
Q1
$323K Hold
351
– – 0.3% 50
2025
Q4
$377K Sell
351
-8
-2% -$7.65K 0.34% 47
2025
Q3
$274K Sell
359
-13
-3% -$9.7K 0.26% 55
2025
Q2
$290K Buy
+372
New +$289K 0.29% 52

Other funds holding LLY

21 West Wealth Management's LLY Position: Q3 2026 in Review

21 West Wealth Management reduced its Eli Lilly (LLY) stake by 3.1% in Q3 2026, selling an estimated $13K and leaving 340 shares worth $393K. The position accounts for 0.34% of the portfolio, ranked #50.

21 West Wealth Management first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. The position peaked at $421K in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • 21 West Wealth Management held 340 shares of Eli Lilly worth $393K as of Q3 2026.
  • 21 West Wealth Management sold 11 Eli Lilly shares in Q3 2026, an estimated $13K.
  • Eli Lilly made up 0.34% of 21 West Wealth Management's portfolio in Q3 2026, its #50 holding.
  • 21 West Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
  • 21 West Wealth Management's Eli Lilly position peaked at $421K in Q2 2026.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on 21 West Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.